DiaMedica Therapeutics Inc.

DMAC

—

Advanced chart & tools →

DiaMedica Therapeutics Inc.DMAC

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-0.65

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$500,000

Net income

$-32.77M

Net margin

-6553.2%

Gross margin

—

Dividends & financials

DiaMedica Therapeutics Inc. (DMAC) reported revenue of $500,000 and net income of $-32.77M, or $-0.65 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.